|
Market Closed -
Other stock markets
|
Pre-market 12:47:04 | |||
| 25.62 USD | -1.61% |
|
25.72 | +0.37% |
| 11:57am | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 06-08 | AstraZeneca's Obesity Pill Helps Patients Lose Weight in Midstage Trials | DJ |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.61% | -0.04% | -0.23% | -5.29% | +2.89% | +9.72% | -34.46% | -34.05% | -27.32% | 146B | |
| +1.57% | +6.19% | +21.16% | +16.04% | +6.93% | +49.26% | +157.85% | +420.68% | +1,434.04% | 1,025B | |
| -0.26% | +3.87% | +4.90% | -3.43% | +12.18% | +49.75% | +44.86% | +42.09% | +100.48% | 559B | |
| -1.83% | +4.76% | +10.68% | -3.06% | -2.37% | +17.51% | +62.07% | +98.57% | +261.36% | 394B | |
| -2.12% | +3.06% | +3.74% | -4.13% | -0.34% | +21.96% | +15.20% | -0.88% | +27.03% | 324B | |
| -1.05% | +3.78% | +7.31% | +3.22% | +13.55% | +51.35% | +8.34% | +65.08% | +107.43% | 295B | |
| -1.42% | +3.03% | +0.83% | -5.73% | -1.28% | +26.38% | +16.24% | +67.45% | +244.40% | 286B | |
| -0.47% | +3.54% | +2.90% | -6.62% | +6.75% | +19.91% | +29.75% | +42.25% | +50.39% | 270B | |
| -1.79% | -3.58% | -10.77% | +5.19% | -17.69% | -48.50% | -50.95% | +5.62% | +42.89% | 186B | |
| -1.10% | +5.04% | +4.23% | -6.44% | +5.63% | +19.08% | +56.61% | +45.99% | +118.82% | 187B | |
| -0.82% | -2.29% | -2.46% | -11.00% | +4.37% | +13.91% | +63.39% | +89.75% | +46.53% | 159B | |
| -2.97% | +1.13% | -1.05% | -7.83% | +3.02% | +14.79% | -14.91% | -12.76% | -24.30% | 113B | |
| -0.87% | +1.04% | +3.06% | -3.01% | -2.29% | -1.67% | +33.19% | +109.80% | +368.29% | 112B | |
| +0.44% | +4.85% | +5.14% | +1.54% | -6.94% | -11.99% | -19.31% | -11.01% | +6.40% | 106B | |
| -1.54% | +3.35% | +2.01% | -8.04% | +3.12% | +24.69% | +36.54% | +9.04% | +4.49% | 102B | |
| -1.19% | -3.18% | -7.26% | -22.19% | -10.52% | -4.99% | +86.03% | +74.66% | +475.50% | 76.66B | |
| -1.49% | +2.58% | -3.62% | -11.43% | +2.90% | +14.74% | +9.65% | +33.88% | +8.89% | 49.78B | |
| -2.42% | -6.57% | -12.99% | -17.31% | -22.88% | -14.61% | +0.77% | -33.56% | +218.29% | 44.88B | |
| -0.80% | +3.96% | -4.40% | -5.69% | -4.22% | +33.85% | -30.69% | -33.13% | -60.71% | 40.49B | |
| -3.59% | -1.17% | -0.98% | -8.89% | -26.53% | -2.88% | +53.42% | +93.38% | +318.09% | 39.01B | |
| Average | -0.93% | +1.63% | +1.11% | -5.21% | -1.69% | +14.11% | +26.18% | +53.64% | +186.05% | 225.82B | |
| Weighted average by Cap. | -0.53% | +3.24% | +6.82% | +0.27% | +3.09% | +27.07% | +55.17% | +128.62% | +416.86% |
- Stock Market
- Stocks
- PFE Stock
- Sector Pfizer Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition